Beijing, November 13, 2018 – 乔治临床( George Clinical ), a leading clinical research organization (CRO) in the Asia-Pacific region, has continued its involvement and collaboration with the Heart Health Research Center (HHRC), further developing the depth and quality of investigator networks. The HHRC, a collaborative initiative developed by Cardio Union, an emerging multi-disciplinary healthcare organization and the parent organization of 乔治临床( George Clinical ), The George Institute for Global Health, provide 乔治临床( George Clinical ) unique access to highly trained cardiovascular investigator networks with significant advantages to sponsors.
“乔治临床( George Clinical ) continues to work with the HHRC’s ground breaking research initiatives and networks,” Philip Gregory, Managing Director of 乔治临床( George Clinical ), China said. “Our engagement with organizations such as the HHRC and researchers such as Prof Craig Anderson, places us in the enviable position as a leading CRO for sponsors looking to conduct cardiovascular and stroke trials in China.”
About 乔治临床( George Clinical )
乔治临床( George Clinical ) is a leading independent Asia-Pacific based clinical research organization (CRO) with global capabilities, differentiated by scientific leadership, innovation and extensive investigator networks. With staff operating in more than 15 countries, 乔治临床( George Clinical ) provides the full range of clinical trial services to biopharmaceutical, medical device and diagnostic customers for all trial phases, registration and post-marketing trials. 乔治临床( George Clinical ) combines scientific and clinical leadership with expert trial delivery capability to create a distinctive world-class service.
About Cardio Union
Cardio Union was co-founded by multiple Chinese well-known cardiologists in June 2015. It has developed into an all-round emerging healthcare industry including tele-medicine, entity medicine, teaching and research, diseases management and academic communication. And become a leading healthcare organization which focuses on the prevention and treatment of cardiology diseases.
Contact: mreabold@georgeclinical.com
Website: georgeclinical.cn
LinkedIn: https://www.linkedin.com/company/george-clinical-pty-ltd
Twitter: https://twitter.com/george_clinical
Facebook: https://www.facebook.com/georgeclinical
For more information, contact:
Donna McDonnell
Business Development Administrator
T 901 229 5345
E dmcdonnell@georgeclinical.com
W georgeclinical.cn | www.georgeinstitute.org
